menu
    • menu

    Company profile for n-Lorem Foundation

    NEW Drugs in Dev: 9
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    n-Lorem’s mission is to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotides (ASO) medicines to treat patients with ultra-rare diseases (<10 patients).n-Lorem is focused on creating individual treatments for patients in the United States with ultra-rare diseases caused by genetic mutations that affect approximately n1-10 patients in the world....
    n-Lorem’s mission is to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotides (ASO) medicines to treat patients with ultra-rare diseases (<10 patients).n-Lorem is focused on creating individual treatments for patients in the United States with ultra-rare diseases caused by genetic mutations that affect approximately n1-10 patients in the world. Diseases or conditions with broader patent populations are likely more suitable for treatment by other non-profit or for-profit entities, which we encourage you to explore with your physician.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    n-Lorem FoundationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2888 Loker Avenue East, Ste. 113 Carlsbad, CA 92010
    Telephone
    Telephone
    (760) 552-7113
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nlorem.org/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    N-Lorem Provides Insight On Commercializing Nano-Rare Medicines
    N-Lorem Provides Insight On Commercializing Nano-Rare Medicines

    19 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-19/n-lorem-publishes-commentary-offering-insight-into-potential-commercialization-strategies-for-nano-r

    PHARMIWEB
    19 Mar 2026
    Share Share
    PacBio to Partner With n-Lorem, EspeRare on Rare Diseases
    PacBio to Partner With n-Lorem, EspeRare on Rare Diseases

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3217022/16261/en/PacBio-Announces-Plans-for-Collaboration-With-n-Lorem-Foundation-and-EspeRare-to-Advance-Precision-Therapies-for-Rare-Genetic-Diseases.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    N-Lorem, Esperare Collaborate To Expand Access To ASO Therapies
    N-Lorem, Esperare Collaborate To Expand Access To ASO Therapies

    12 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/n-lorem-and-esperare-announce-european-collaboration-to-expand-access-to-individualized-aso-therapies-for-rare-genetic-diseases-302658829.html

    PR NEWSWIRE
    12 Jan 2026
    Share Share
    N-Lorem Foundation Hosts 3rd Nano-Rare Patient Colloquium
    N-Lorem Foundation Hosts 3rd Nano-Rare Patient Colloquium

    02 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251002216594/en/n-Lorem-Foundation-Organizes-Third-Annual-Nano-rare-Patient-Colloquium-Highlighting-Scientific-and-Clinical-Advancements-Achieved-Since-Organizations-Founding

    BUSINESSWIRE
    02 Oct 2025
    Share Share
    n-Lorem Study Shows ASO Restores GBE1 in APBD Patient Cells
    n-Lorem Study Shows ASO Restores GBE1 in APBD Patient Cells

    19 Aug 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250819544430/en/n-Lorem-Foundation-Publishes-Study-Showing-Targeted-ASO-Therapy-Restores-GBE1-Protein-in-APBD-Patient-Cells

    BUSINESSWIRE
    19 Aug 2025
    Share Share
    n-Lorem Foundation Celebrates 5 Years Helping Nano-rare Patients
    n-Lorem Foundation Celebrates 5 Years Helping Nano-rare Patients

    15 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250415314745/en/n-Lorem-Foundation-Celebrates-Five-Years-of-Bringing-Hope-and-Potential-Treatments-to-Nano-rare-Patients

    BUSINESSWIRE
    15 Apr 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search